NovaBridge Biosciences (NBP) Shares Outstanding (2018 - 2025)

NovaBridge Biosciences (NBP) has reported Shares Outstanding (Entity) for 8 consecutive years, with $95.8 million the latest figure, recorded in Q4 2025.

• Quarterly Shares Outstanding (Entity) changed N/A year-over-year to $95.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $95.8 million (changed N/A YoY) and the FY2025 annual result came in at $95.8 million, changed N/A from the prior year.
• Shares Outstanding (Entity) advanced to $95.8 million in Q4 2025 per NBP's latest filing, from $89.2 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for NBP reached as high as $95.8 million in Q4 2025 and fell as low as $7.4 million in Q2 2021.
• A 5-year average of $46.9 million and a median of $46.2 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) dropped 4.62% — and 2024, when it jumped 943.94%.
• Year by year, Shares Outstanding (Entity) stood at $7.7 million in 2021, then fell by 2.35% to $7.6 million in 2022, then surged by 52.75% to $11.6 million in 2023, then surged by 601.43% to $81.1 million in 2024, then rose by 18.11% to $95.8 million in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $95.8 million, $89.2 million, and $81.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.